The American Association for Cancer Research (AACR) held their annual meeting in San Diego, CA from April 17-22, 2026. The AACR Annual Meeting gathers cancer researchers from around the world […]
Unprecedented Results from Revolution Medicines for Patients with Metastatic Pancreatic Cancer
Revolution Medicines announced exciting results on three clinical trials evaluating daraxonrasib, their oral RAS inhibitor, that have the potential to transform treatment options for patients with metastatic pancreatic ductal adenocarcinoma […]
Momentum Newsletter: Spring 2026
This spring, progress is taking shape across every part of our work. From advancing research to expanding programs that reach more patients than ever before, we are helping hope bloom. […]
Keeping Patients Moving Forward: CancerCare’s 2025 Year-End Impact
Since 1998, the Hirshberg Foundation has partnered with CancerCare to help families navigate the financial and emotional challenges that follow a pancreatic cancer diagnosis. With your generosity, we provide bi-annual […]
Promising results combining immunotherapy and chemotherapy before surgery in pancreatic cancer
A recent study published in Nature Communications, sponsored by the UCLA Health Jonsson Comprehensive Cancer Center, showed that adding immunotherapy to standard chemotherapy, before surgery, may benefit a subset of […]
pNET Treatments and Emerging Research
As an overview of Pancreatic Neuroendocrine Tumors, we look at the current standard treatment for pNETs and what emerging therapies are on the horizon. Also discussed is the translational research […]
